3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

Signal Transduct Target Ther. 2022 Mar 14;7(1):84. doi: 10.1038/s41392-022-00937-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Viral Vaccines*

Substances

  • Viral Vaccines